Thanks as always Hottod for sharing so generously your amazing research on and around NEU. Spookily without having read these very latest posts, during one of my awake moments last night , I posed to myself if the the safety profile of NNZ 2591 was so brilliant and so many indications responsive to it, and presumably ( my assumption ) the earlier the IGF shortage / malfunction was addressed the better the outcomes, would it worthwhile giving all infants a course? With its properties we know that extensive distribution is a practical possibility. Obviously the price would need to tumble but conversely the volume would explode. Firstly, from the most critical aspect, health benefit / cost outcomes is it viable. Secondly can that volume of compound be produced ? How complex a process is the production of NNZ2591?
NEU Price at posting:
$13.79 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)